Q4Bio
Runs a United Kingdom-linked program connecting quantum hardware and life-science teams to tackle hard biological problems.
Q4Bio is Wellcome Leap’s quantum-for-biology program, built around the idea that near-term quantum hardware could solve biological problems that are still out of reach for classical methods. It sits inside Wellcome Leap’s active program portfolio and is already in execution, with performer teams selected and the work moving on a three- to five-year hardware horizon. The total scale is about $50 million, combining research funding and challenge prizes. The primary funding mechanism is a cooperative-agreement model for multidisciplinary, multi-organization teams that bring together health science, quantum software, and quantum hardware expertise. The research side reaches up to $40 million, while the prize side adds up to $10 million, including $2 million per team for a successful quantum demonstration and a $5 million grand prize for one team that clears the stated quantum-resource target. The program is structured around a timeline that matches the expected emergence of useful quantum computers. That setup favors teams that can coordinate across disciplines and deliver proof of capability rather than single-lab proposals. There is no open solicitation visible in the source material, so the practical route is participation in the existing performer cohort. The best fit is a group that can connect a biological question to a testable quantum plan and keep the technical pieces aligned long enough to produce a real demonstration.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.